12:00 AM
 | 
Jun 04, 2012
 |  BC Week In Review  |  Company News  |  Deals

Roche, German Cancer Research Center, Heidelberg University Hospital deal

The cancer center and the hospital granted Roche's Ventana Medical Systems Inc. tissue diagnostic unit exclusive, worldwide rights to commercialize an immunohistochemistry antibody assay to detect BRAF V600E mutations. Ventana expects to...

Read the full 146 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >